Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Acetazolamide for Patients With Treatment Resistant Schizophrenia

NCT04887792 is registered in ClinicalTrials.gov with Vishwajit Nimgaonkar, MD PhD as lead sponsor.

NCT NCT04887792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Acetazolamide for Patients With Treatment Resistant Schizophrenia
Lead sponsor
Vishwajit Nimgaonkar, MD PhD
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 1, 2022
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizo affective disorder, schizophrenia